About Anpac Bio
Anpac Bio is a company based in California City (United States) founded in 2010 by Herbert Yu. Anpac Bio has completed 6 acquisitions, including Fresh2, GISN and GISN. Anpac Bio operates in a competitive market with competitors including Guardant Health, Denali Therapeutics, Foundation Medicine, ArcherDX and MiRagen, among others.
- Headquarter California City, United States
- Founders Herbert Yu
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Fresh2 Group Limited Spon Ads Each Repr 200 Ord Shs (P/S)
-
Annual Revenue
$1.79 M (USD)-35.86as on Dec 31, 2022
-
Net Profit
-$15.13 M (USD)17.78as on Dec 31, 2022
-
EBITDA
-$11.68 M (USD)27.08as on Dec 31, 2022
-
Latest Funding Round
$5 M (USD), Post-IPO
Mar 01, 2023
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
Fresh2
& 5 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Anpac Bio
Anpac Bio is a publicly listed company on the OTC with ticker symbol FREHY in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Anpac Bio
Unlock access to complete
Unlock access to complete
Funding Insights of Anpac Bio
Investors in Anpac Bio
Anpac Bio has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Keystone Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
An investment firm based in New York is operated.
|
Locked | Locked | Locked |
Investor details for Anpac Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Anpac Bio
Anpac Bio has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Fresh2, GISN and GISN.
Investment portfolio details for Anpac Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Multi-category grocery products are supplied via an online B2B marketplace.
|
Locked | Locked | 2022 | Locked | |
|
Technology consulting services are provided by GISN since 2021.
|
Locked | Locked | 2021 | Locked | |
|
Provider of operation model and technical & outsourcing consulting services
|
Locked | Locked | 2016 | Locked |
Complete acquisition details for Anpac Bio
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Anpac Bio
Detailed financials for Anpac Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Anpac Bio Comparisons
Peer comparison for Anpac Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Anpac Bio
Anpac Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Denali Therapeutics, Foundation Medicine, ArcherDX and MiRagen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
Detailed competitors of Anpac Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Anpac Bio
Complete news archive for Anpac Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anpac Bio
Anpac Bio was founded in 2010 and raised its 1st funding round 10 years after it was founded.
Anpac Bio is headquartered in California City, United States. It is registered at California City, California, United States.
Annual revenue of Anpac Bio is $1.79M as on Dec 31, 2022.
Anpac Bio was founded in 2010 in California City, United States, within the biotechnology sector focused on cancer diagnostics. Cancer Differentiation Analysis (CDA) technology is employed to screen for early cancer detection through standard blood samples. Overall cancer risk is evaluated for individuals, and potential tumor locations are identified when combined with existing biomarker tests. Operations center on providing non-invasive screening platforms for risk assessment.
Anpac Bio's top competitors include Guardant Health, Strand Life Sciences and Juno Therapeutics.
Yes, Anpac Bio is publicly traded on OTC under the ticker symbol FREHY.
Anpac Bio has 1 investor. Key investors include Keystone Capital Partners.
The ticker symbol of Anpac Bio is FREHY on OTC.